p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients

This publication has 28 references indexed in Scilit:

• Improving the Detection of p53 Mutations in Breast Cancer by Use of the FASAY, a Functional Assay
  The Journal of Molecular Diagnostics, 2000
• High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay
  Oncogene, 1997
• Field cancerisation and polyclonal p53 mutation in the upper aero- digestive tract
  Oncogene, 1997
• Cell status — dead or alive?
  Nature Medicine, 1996
• The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry
  JNCI Journal of the National Cancer Institute, 1996
• Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis
  Nature Medicine, 1996
• CANCER BIOLOGY: Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein
  Carcinogenesis: Integrative Cancer Research, 1996
• p53 Status and the Efficacy of Cancer Therapy in Vivo
  Science, 1994
• Sample size requirements and length of study for testing interaction in a 1 × k factorial design when time-to-failure is the outcome
  Controlled Clinical Trials, 1993
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
  Cell, 1993